Key, Dates

Key Dates and Financial Crossroads for Oxford Square Capital Investors

29.01.2026 - 19:25:04

Oxford Square Capital US69181V1070

February presents a significant period for shareholders of Oxford Square Capital, with critical financial disclosures and a dividend payment on the calendar. The business development company (BDC) faces a pivotal moment as it prepares to report quarterly results that will shed light on the health of its investment portfolio following a challenging period.

The most anticipated event is the scheduled release of the company's financial results on February 26. This report is considered crucial for a long-term assessment, as it will provide detailed insight into recent portfolio performance. Market participants are keenly focused on the stability of the net asset value (NAV), seeking evidence of a sustainable recovery. This scrutiny follows a reported net loss of approximately $2.56 million over the prior twelve-month period, placing analyst attention squarely on the earning power of the underlying credit investments.

Oxford Square Capital’s strategy is heavily concentrated in corporate loans and collateralized loan obligations (CLOs), with a notable focus on the technology and software sectors. These asset classes are particularly sensitive to prevailing interest rates and broader credit market conditions.

Should investors sell immediately? Or is it worth buying Oxford Square Capital?

Dividend Payment and Recent Performance

Income-focused investors also have a key date marked: February 13, 2026, is the next ex-dividend date. The company maintains a practice of regular monthly distributions, which currently aggregate to an annual payout of about $0.42 per share.

Despite a year-to-date share price appreciation of nearly eleven percent, the stock remains down roughly 24 percent over a trailing twelve-month horizon. The upcoming quarterly figures must demonstrate whether this recent rebound is supported by fundamental improvements in the portfolio's structure or if risks associated with its CLO investments continue to pose significant headwinds.

The Path Forward

The February 26 earnings release represents the next major milestone for valuation. Investors will dissect the report to gauge the NAV's resilience, aiming to better assess the potential for future write-downs. The findings will be instrumental in determining if Oxford Square Capital is on a path to sustained stabilization.

Ad

Oxford Square Capital Stock: Buy or Sell?! New Oxford Square Capital Analysis from January 29 delivers the answer:

The latest Oxford Square Capital figures speak for themselves: Urgent action needed for Oxford Square Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 29.

Oxford Square Capital: Buy or sell? Read more here...

@ boerse-global.de | US69181V1070 KEY